Key result
Primary angiosarcoma of the ovary is an aggressive tumor with rapid progression and poor prognosis, as the patient died 5 months after optimal surgical debulking and palliative chemotherapy.
Case Report (n=1)
Primary angiosarcoma of the ovary is an aggressive tumor with poor prognosis despite optimal surgical treatment.
Alerts clinicians to rare ovarian angiosarcoma in postmenopausal abdominal symptoms; leaves optimal management open.
Primary angiosarcoma of the ovary is a rare and aggressive subset accounting for less than 1% of ovarian malignancies. We present a rare case of primary angiosarcoma of the ovary in a 52-year-old healthy postmenopausal woman who presented with mild abdominal pain, distension and poor appetite of 1 week duration. On abdominal examination, right iliac fossa fullness with shifting dullness was noted. A CT of abdomen and pelvis revealed a right 10.5 cm complex solid cystic mass with ascites and peritoneal nodularity. Her CA125 was 560 U/mL. She subsequently underwent full surgical staging and optimal debulking surgery. Final histology confirmed angiosarcoma of ovary grade 3 FIGO stage IIA ovarian cancer. A repeat CT of abdomen and pelvis done 4 weeks later prior to starting chemotherapy showed large 6.5 × 6 cm pelvic peritoneal deposits with cystic septation and solid components. Her disease progressed despite palliative chemotherapy and she unfortunately passed away several months after surgery. We reiterate that primary angiosarcoma of the ovary is an aggressive tumor with poor prognosis despite optimal surgical treatment. J Med Cases. 2016;7(9):393-395 doi: https://doi.org/10.14740/jmc2606w
No takes yet. Share an insight, caveat, or question.
Bhutia et al. (2016) conducted a case report in Primary angiosarcoma of the ovary (n=1). Surgical debulking and palliative chemotherapy (doxorubicin) was evaluated on Survival and disease progression. Primary angiosarcoma of the ovary is an aggressive tumor with rapid progression and poor prognosis, as the patient died 5 months after optimal surgical debulking and palliative chemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: